Bruce D. Mazer

McGill University - Meakins-Christie Laboratories

Montreal

Canada

SCHOLARLY PAPERS

4

DOWNLOADS

163

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (4)

1.

The Effect of Dose-Interval on Antibody Response to mRNA COVID-19 Vaccines: A Prospective Cohort Study

Number of pages: 34 Posted: 10 Oct 2023
McGill University - McGill University Health Centre, McGill University - McGill University Health Centre, McGill University - Meakins-Christie Laboratories, McGill University, McGill University, McGill University, McGill University, McGill University, McGill University, McGill University, McGill University, McGill University, University of Ottawa - Department of Biochemistry, Microbiology and Immunology, University of Ottawa, University of Ottawa, University of Ottawa, University of Ottawa - Department of Biochemistry, Microbiology and Immunology, McGill University and McGill University - Meakins-Christie Laboratories
Downloads 53 (696,389)

Abstract:

Loading...

COVID-19, mRNA Vaccination, Vaccine response, Humoral immunity, Vaccine dosing intervals

2.

Identification of Individuals at High Risk of Adverse Outcomes from COVID-19: A Systematic Review

Number of pages: 17 Posted: 16 Oct 2023
University of Exeter, CommPharm Consulting, University of Toronto - St. Michael’s Hospital, RESPIPLUS, University of British Columbia (UBC), McGill University, Canadian Heart Research Centre, McGill University - Meakins-Christie Laboratories, McGill University, University of Toronto - St. Michael’s Hospital, RESPIPLUS and Respiratory Epidemiology and Clinical Research Unit, Research Institute of McGill University Health Centre, McGill University, Montreal, Canada
Downloads 50 (714,876)

Abstract:

Loading...

high-risk COVID-19, high-risk populations, severe outcomes, COVID-19, mortality, hospitalization, respirology, immunology, cardiovascular disease, nephrology, neurology, endocrinology, preventative management, therapeutic management, COVID-19 risk factors

3.

Real-World Serologic Responses to Extended-Interval and Heterologous COVID-19 mRNA Vaccination in Frail Elderly - Interim Report from a Prospective Observational Cohort Study

Number of pages: 24 Posted: 22 Sep 2021
McGill University - Infectious Diseases and Immunity in Global Health Program, Concordia University, QuebecCentre de Recherche de l'Institut Universitaire de Gériatrie Montréal (CRIUGM), Centre de Recherche de l'Institut Universitaire de Gériatrie Montréal (CRIUGM), McGill University - Infectious Diseases and Immunity in Global Health Program, McGill University - Infectious Diseases and Immunity in Global Health Program, Centre de Recherche de l'Institut Universitaire de Gériatrie Montréal (CRIUGM), McGill University - Infectious Diseases and Immunity in Global Health Program, McGill University - Infectious Diseases and Immunity in Global Health Program, McGill University - Infectious Diseases and Immunity in Global Health Program, McGill University - Infectious Diseases and Immunity in Global Health Program, McGill University - Infectious Diseases and Immunity in Global Health Program, McGill University - Infectious Diseases and Immunity in Global Health Program, McGill University - Infectious Diseases and Immunity in Global Health Program, McGill University - Infectious Diseases and Immunity in Global Health Program, McGill University - Infectious Diseases and Immunity in Global Health Program, McGill University - Meakins-Christie Laboratories, University of Ottawa - Department of Biochemistry, Microbiology and Immunology, University of Ottawa - Department of Biochemistry, Microbiology and Immunology, University of Ottawa - Department of Biochemistry, Microbiology and Immunology, McGill University - School of Population and Global Health, McGill University - Centre for Outcomes Research and Evaluation, McGill University - Meakins-Christie Laboratories and Independent
Downloads 48 (727,550)

Abstract:

Loading...

COVID-19, SARS-CoV-2, mRNA-1273, BNT162b2, antibody responses, frail elderly

4.

Clinical Performance of Three Commercial and Two In-House Multiplex Assays for SARS-CoV-2 Antibody Detection in Dried Blood Spot Specimens

Number of pages: 121 Posted: 14 Mar 2022
Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, University of Ottawa, University of Ottawa, University of Ottawa - Department of Biochemistry, Microbiology and Immunology, Sinai Health System TorontoUniversity of Toronto - Centre for Global Health Research, University of Toronto - Mount Sinai Hospital, Toronto, University of Toronto, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, National Research Council Canada, McGill University, McGill University - Meakins-Christie Laboratories, Public Health Agency of Canada and Public Health Agency of Canada
Downloads 12 (1,037,594)

Abstract:

Loading...